Literature DB >> 9141207

Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection.

R Weltzin1, H Kleanthous, F Guirakhoo, T P Monath, C K Lee.   

Abstract

Intranasal (i.n.) delivery of antigen can be highly effective for generating circulating and secretory antibody responses. Mice were immunized i.n. with two antigens, human IgA, and Helicobacter pylori urease in the presence or absence of mucosal adjuvant. To restrict antigen delivery to the upper airways, protein solutions were administered in a small volume without anesthesia. Repeated daily i.n. administration of antigen without adjuvant elicited high levels of specific IgG in serum and IgA in serum, saliva, and feces. Once weekly i.n. immunization with co-administration of cholera toxin or Escherichia coli heat-labile toxin as adjuvant elicited somewhat lower levels of antibody to urease. When challenged with Helicobacter felis, only mice immunized with urease in the presence of adjuvant were protected against gastric infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9141207     DOI: 10.1016/s0264-410x(97)00203-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

1.  Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice.

Authors:  N B Saunders; D R Shoemaker; B L Brandt; E E Moran; T Larsen; W D Zollinger
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

2.  Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection.

Authors:  H Kleanthous; G A Myers; K M Georgakopoulos; T J Tibbitts; J W Ingrassia; H L Gray; R Ding; Z Z Zhang; W Lei; R Nichols; C K Lee; T H Ermak; T P Monath
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 3.  Intranasal antibody prophylaxis for protection against viral disease.

Authors:  R Weltzin; T P Monath
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

Review 4.  Vaccinating against Helicobacter pylori in the developing world.

Authors:  Shamila Zawahir; Steven J Czinn; John G Nedrud; Thomas G Blanchard
Journal:  Gut Microbes       Date:  2013-11-06

5.  Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits.

Authors:  I E Corthésy-Theulaz; S Hopkins; D Bachmann; P F Saldinger; N Porta; R Haas; Y Zheng-Xin; T Meyer; H Bouzourène; A L Blum; J P Kraehenbuhl
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

6.  Childhood Helicobacter pylori infection in a murine model: maternal transmission and eradication by systemic immunization using bacterial antigen-aluminium hydroxide.

Authors:  T Minoura; S Kato; S Otsu; T Fujioka; K Iinuma; A Nishizono
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

7.  Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations.

Authors:  Michael Vajdy; Manmohan Singh; Mildred Ugozzoli; Maylene Briones; Elawati Soenawan; Lina Cuadra; Jina Kazzaz; Paolo Ruggiero; Samuele Peppoloni; Francesco Norelli; Giuseppe del Giudice; Derek O'Hagan
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

8.  Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates.

Authors:  Klaus Panthel; Wolfgang Jechlinger; Alexander Matis; Manfred Rohde; Michael Szostak; Werner Lubitz; Rainer Haas
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent.

Authors:  Christine A Garhart; Frederick P Heinzel; Steven J Czinn; John G Nedrud
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

10.  Colonization of C57BL/6J and BALB/c wild-type and knockout mice with Helicobacter pylori: effect of vaccination and implications for innate and acquired immunity.

Authors:  Klaus Panthel; Gerhard Faller; Rainer Haas
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.